Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingSep 4, 2024IBU Ibuprofen TabletsFailed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.Dr. Reddy's Laboratories, Inc. · D-0644-2024Class IIOngoingSep 4, 2024Indomethacin Extended-Release CapsulesFailed Dissolution Specifications: below specification resultsGlenmark Pharmaceuticals Inc., USA · D-0643-2024Class IIOngoingAug 28, 2024Timolol Maleate Ophthalmic Solution USPDefective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.FDC Limited · D-0642-2024Class IOngoingAug 28, 2024Healthy Living AcetaminophenLabeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.Aurobindo Pharma USA Inc · D-0641-2024Class IICompletedAug 28, 2024HAND-I-SANCGMP Deviations: sterile water not used for productionZeco LLC · D-0640-2024Class IICompletedAug 28, 2024Rubbing AlcoholCGMP Deviations: sterile water not used for productionZeco LLC · D-0639-2024Class IOngoingAug 28, 20240.9% Sodium Chloride Injection USPPresence of Particulate MatterB. Braun Medical Inc · D-0638-2024Class IIOngoingAug 28, 2024Testosterone GelSuperpotent DrugTeva Pharmaceuticals USA, Inc · D-0637-2024Class IIOngoingAug 28, 2024Lidocaine HCl InjectionLack of Assurance of SterilityFagron Compounding Services · D-0636-2024Class IOngoingAug 28, 2024Acetaminophen InjectionLabeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL...Hikma Pharmaceuticals USA Inc. · D-0635-2024Class IIICompletedAug 21, 2024Hydrocortisone 1% & Acetic Acid 2% Otic SolutionFailed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the...Taro Pharmaceuticals U.S.A., Inc. · D-0633-2024Class IIOngoingAug 21, 2024Timolol Maleate Ophthalmic Solution USPDefective container; yellow colored spike from cap lodged in the nozzleFDC Limited · D-0632-2024Class IITerminatedAug 14, 2024Gabapentin TabletsPresence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin TabletsGranules Pharmaceuticals Inc. · D-0634-2024Class ITerminatedAug 14, 2024Acetaminophen Extra Strength TabletsLabeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.A-S Medication Solutions LLC · D-0631-2024Class IITerminatedAug 14, 2024Empower PharmacyLack of Assurance of SterilityEmpower Clinic Services LLC · D-0630-2024Class IIICompletedAug 14, 2024Methotrexate TabletsPresence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.Amneal Pharmaceuticals, LLC · D-0629-2024Class IIITerminatedAug 14, 2024PEG-3350Defective container: potential for non-sealed pouches which can lead to product leakage.Novel Laboratories, Inc. d.b.a Lupin Somerset · D-0628-2024Class IIITerminatedAug 14, 2024AcetaminophenLabel mix-up: Carton incorrectly labeled.Granules Consumer Health Inc. · D-0627-2024Class IOngoingAug 14, 2024Umary Acido HialuronicoMarketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.Main Products Inc · D-0626-2024Class IIIOngoingAug 14, 2024Sevelamer Carbonate for Oral Suspension 0.8g packetsLabeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packetsDr. Reddy's Laboratories, Inc. · D-0625-2024Class IIOngoingAug 7, 2024Progesterone InjectionPresence of Particulate Matter: Complaint received of a glass particle in the vial.Eugia US LLC · D-0624-2024Class IIOngoingAug 7, 2024Ciprofloxacin ophthalmic solution USPDefective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.FDC Limited · D-0623-2024Class ITerminatedAug 7, 2024Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect...Endo Pharmaceuticals, Inc. · D-0622-2024Class IIOngoingAug 7, 2024GlenmarkCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0621-2024Class IOngoingAug 7, 2024Umary Acido HialuronicoMarketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.SoloVital · D-0620-2024Class IOngoingAug 7, 2024Potassium Chloride Extended-Release CapsulesFailed Dissolution SpecificationsAmerisource Health Services LLC · D-0619-2024Class IIITerminatedJul 31, 2024Complete 30C/200C Homeopathic KitLabeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.Washington Homeopathic Products, Inc. · D-0618-2024Class IITerminatedJul 31, 2024Venlafaxine Hydrochloride Extended-Release CapsulesFailed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.Zydus Pharmaceuticals (USA) Inc · D-0617-2024Class IIIOngoingJul 31, 2024Hemp Bombs CBD Pain FreezeSubpotent drug: The potency of the active (menthol) was less than the label claim of 4%.Global Widget LLC · D-0616-2024Class IIIOngoingJul 31, 2024Hemp Bombs CBD Pain FreezeSubpotent drug: The potency of the active (menthol) was less than the label claim of 4%.Global Widget LLC · D-0615-2024Class IIIOngoingJul 31, 2024Nature's Script CBD Cryotherapy Pain Relief Roll onSubpotent drug: The potency of the active (menthol) was less than the label claim of 4%.Global Widget LLC · D-0614-2024Class IIIOngoingJul 31, 2024Hemp Bombs CBD Pain FreezeSubpotent drug: The potency of the active (menthol) was less than the label claim of 4%.Global Widget LLC · D-0613-2024Class IIOngoingJul 24, 2024Pravastatin Sodium TabletsFailed Dissolution Specifications: results below specificationsGlenmark Pharmaceuticals Inc., USA · D-0612-2024Class IITerminatedJul 24, 2024Potassium Chloride Micro 10mEq KCGMP Deviations: Out of specification for dissolutionRemedyRepack Inc. · D-0611-2024Class IITerminatedJul 24, 2024STELLALIFE ADVANCED FORMULA PeppermintMicrobial Contamination of Non-Sterile Products: presence of Terribacillus species organismHomeocare Laboratories, Inc. · D-0610-2024Class ITerminatedJul 24, 2024STELLALIFE VEGA Oral CareMicrobial Contamination of Non-Sterile Products: multiple Bacillus species organismsHomeocare Laboratories, Inc. · D-0609-2024Class IIOngoingJul 24, 2024DELFLEX PERITONEAL DIALYSIS SOLUTION With LOW MAGNESIUM / LOW CALCIUM 4.25% DEXTROSE and attached stay "safe...This product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.Fresenius Medical Care Holdings, Inc. · D-0608-2024Class IIOngoingJul 24, 2024Potassium Chloride Extended-Release CapsulesCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0607-2024Class IIOngoingJul 24, 2024Potassium Chloride Extended-Release CapsulesCGMP DeviationsGlenmark Pharmaceuticals Inc., USA · D-0606-2024Class IOngoingJul 24, 2024Potassium Chloride Extended-Release CapsulesFailed Dissolution SpecificationsGlenmark Pharmaceuticals Inc., USA · D-0605-2024